C.D.C. Panel Is Set to Discuss Johnson & Johnson Blood Clot Risk
Officials are concerned by an increase in a rare but serious blood clotting disorder linked to the drugmaker’s vaccine. Here’s the latest pandemic news.
Full Article
C.D.C. Panel Is Set to Discuss Johnson & Johnson Blood Clot Risk
NYTimes.com
0 shares
1 views
You might like
Related news coverage
C.D.C. Panel Recommends Other Covid Vaccines Over J.&J.’s Shots
NYTimes.com
A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to..